Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis

Cell Mol Gastroenterol Hepatol. 2021;11(2):663-664. doi: 10.1016/j.jcmgh.2020.10.013. Epub 2020 Nov 18.

Authors

Jain Jeong¹, Yasuko Iwakiri²

Affiliations

¹ Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut.
² Department of Internal Medicine, Section of Digestive Diseases, Yale School of Medicine, New Haven, Connecticut. Electronic address: yasuko.iwakiri@yale.edu.

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Non-alcoholic Fatty Liver Disease* / drug therapy

Grants and funding